Florida Cancer Specialists & Research Institute Participates in Statewide Gathering to Enhance Cancer Care in Community Oncology Settings

Fort Myers, Fla., May 2, 2024 – Florida Cancer Specialists & Research Institute, LLC (FCS) physicians and senior leaders are participating in the Florida Society of Clinical Oncology (FLASCO) 2024 Business of Oncology Summit & Spring Session this week in Kissimmee, FL. The two-day event provides opportunities for medical providers, patients, payors and other oncology stakeholders from across Florida to delve into evolving topics impacting both clinical and non-clinical aspects of community oncology.

Image Credit: © Florida Cancer Specialists & Research Institute, LLC

Lucio N. Gordan, MD, FCS President & Managing Physician, said, “Our leadership and participation in this collaborative platform enhances our ability to navigate current and future challenges in the landscape of cancer care and, most important, our capabilities to provide our patients with the highest quality of care.”

Maen Hussein, MD, FCS medical oncologist and hematologist and FLASCO President, will open the Spring Session, addressing physicians, advanced practice providers, nurses, practice administrators, pharmacists, social workers and financial counselors. Discussions will focus on the integration of AI technology in clinical practice, as well as cutting-edge updates in breast and lung cancer treatment and the integration of bispecifics and CAR-T therapies.

FCS medical oncologist and hematologist Paresh Patel, MD, who serves as FLASCO State Legislative Chair, will moderate a Business of Oncology panel session titled, “Regulatory and Legislative Drivers Impacting Oncology Practice: The Expanding Infusion Landscape and What it Means for Clinicians.” Other panels will debate around topics that include future of community oncology and new players in the oncology space, inclusive of physicians, venture capitalists and distributers.

The following FCS physicians and senior leaders also hold leadership positions with FLASCO:

• Faithlore Gardner, MD, Treasurer, and Barry Berman, MD, MS, Finance Chairman
• Nalini Hasija, MD, Cesar Augusto Perez, MD and Magali Van den Bergh, MD, Board Members
• Michael Diaz, MD, Past President and Director of Advocacy, and Richard McDonough, MD, Past President and Director of Fellowship Programs
• FCS Vice President of Marketing Michelle Robey, Marketing & Communications Liaison, and FCS Director of Pharmacy Operations Kristen Boykin, PharmD, BCOP, BCPS, Pharmacist Liaison

The Florida Society of Clinical Oncology (FLASCO) is a statewide non-profit organization committed to facilitating and promoting multidisciplinary efforts for oncology practitioners and industry professionals to improve patient care in Florida.